MRNA MRNA

Moderna Stock Price

175.91
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
175.91
Volume 0
Bid Price 175.65
Ask Price 176.59
News -
Day High

Low
115.03

52 Week Range

High
336.3599

Day Low
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 175.91 19:00:00
Open Price Low Price High Price Close Price Prev Close
175.91
Trades Volume Avg Volume 52 Week Range
0 0 - 115.03 - 336.3599
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 175.91 USD

Period:

Draw Mode:

Moderna Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 67.58B 384.18M 283.08M $ 17.74B $ 9.99B 56.58 3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.05M 5.80%

more financials information »

Moderna News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week175.01184.21169.06175.112,881,4250.900.51%
1 Month138.76188.65135.09170.864,209,80637.1526.77%
3 Months136.70188.65115.03143.354,776,68239.2128.68%
6 Months146.09197.44115.03148.264,858,78829.8220.41%
1 Year329.75336.3599115.03173.556,526,518-153.84-46.65%
3 Years20.30497.1717.68154.8012,376,534155.61766.55%
5 Years22.00497.1711.54149.459,741,550153.91699.59%

Moderna Description

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.